Search

We are urgently seeking Enterococcus faecium phages for a critically-ill patient in Germany. Ways to help at this stage: - By sending your phages for testing on the patient's strain - By receiving the strain and testing your phages - By h

Harald Brüssow, guest editor of the recently completed "Hurdles for Phage Therapy to Become a Reality" issue of Viruses, has written an editorial on the work (30 papers) published in the issue. His take-home lessons for optimizing phage the

##### Call for Posters for Phage Futures Europe, Brussels, September 25-26 Looking to showcase your recent work to the phage therapy community? Phage Futures Europe is accepting abstract submissions for poster presentations. Your poster wil

Mian Li Ooi and colleagues at the University of Adelaide and Ampliphi Biosciences published a paper on their use of phage therapy in a phase I clinical trial to treat patients with chronic rhinosinusitis caused by Staphylococcus aureus. The

PhagoMed, an Austrian phage therapy company, announced this week that it’s received 1.5 million Euro in additional investment!

Listen to Paul Turner of Yale describe his group’s phage research and phage therapy work (they’ve treated 16 patients so far!) on This Week in Evolution (TWiEVO), an ASM podcast. This one was recorded live at last week’s ASM Microbe confere

PhagoMed, an Austrian phage therapy company, announced this week that it’s received 1.5 million Euro in additional investment!

Listen to Paul Turner of Yale describe his group’s phage research and phage therapy work (they’ve treated 16 patients so far!) on This Week in Evolution (TWiEVO), an ASM podcast. This one was recorded live at last week’s ASM Microbe confere

##### Call for Posters for Phage Futures Europe, Brussels, September 25-26 Looking to showcase your recent work to the phage therapy community? Phage Futures Europe is accepting abstract submissions for poster presentations. Your poster wil

Mian Li Ooi and colleagues at the University of Adelaide and Ampliphi Biosciences published a paper on their use of phage therapy in a phase I clinical trial to treat patients with chronic rhinosinusitis caused by Staphylococcus aureus. The

Ness Ziona, Israel BiomX is a leading Israeli biotech company developing microbiome-based novel therapeutics. We are looking for a highly-motivated M.Sc.-level research assistant to join our Microbiology team. By joining this team, you will

A 13-month old infant was successfully treated with phage therapy (English article | Dutch article) post-liver transplant at the Saint-Luc University Hospital in Brussels. Phages were obtained from the Queen Astrid Military Hospital—read mo

This NPR article discusses Locus Biosciences' upcoming E. coli urinary tract infection phage therapy trial and interviews one of the trial volunteers—Alfonso Evans, a US Army veteran who was paralyzed by a spinal cord injury and thus suffer

An interesting reflection by Prof. Marc Bonten of UMC Utrecht on the current impasse in the Netherlands when it comes to the need for phage clinical trials, and on UMCU's recent discussions with national health authorities on the matter.

BiomX, a phage therapy biotech company, just announced that it's licensed new bacterial targets for commercialization of phage therapies for Primary Sclerosing Cholangitis (PSC; a rare, progressive liver disease). The targets: strains of Kl

Intralytix announced that it will be collaborating with the Eliava Foundation and Ferring Pharmaceuticals to develop new phage-based drugs to improve reproductive medicine and women's health through modulation of the vaginal microbiome.

A new paper by Saima Aslam and colleagues at the Center for Innovative Phage Applications and Therapeutics (IPATH) at UC San Diego reports their early clinical experience with phage therapy in lung transplant recipients.

Md. Shamim Ahasan and colleagues at James Cook University in Queensland, Australia have published a study comparing phage therapy to antibiotics in treating gut dysbiosis in endangered green turtles. They found that phages (isolated from se

A new paper by Saima Aslam and colleagues at the Center for Innovative Phage Applications and Therapeutics (IPATH) at UC San Diego reports their early clinical experience with phage therapy in lung transplant recipients.

Intralytix announced that it will be collaborating with the Eliava Foundation and Ferring Pharmaceuticals to develop new phage-based drugs to improve reproductive medicine and women's health through modulation of the vaginal microbiome.